Profil
Pietro Scalfaro served as a Director on the Supervisory Board of Agendia NV, Director of Diagnoplex SA, Non-Executive Director of Biocartis SA, and Chief Medical Officer of Immunexpress Pty Ltd. He received his undergraduate degree from the University of Lausanne in 1989.
Ehemalige bekannte Positionen von Pietro Scalfaro
| Unternehmen | Position | Ende |
|---|---|---|
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Direktor/Vorstandsmitglied | 01.04.2013 |
Immunexpress Pty Ltd.
Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Engages in creating molecular diagnostics for sepsis | Technik-/Wissenschafts-/F&E-Leiter | - |
Diagnoplex SA
Diagnoplex SA Medical SpecialtiesHealth Technology Develops molecular diagnostics for colon cancer | Direktor/Vorstandsmitglied | - |
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Direktor/Vorstandsmitglied | - |
Ausbildung von Pietro Scalfaro
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Health Services |
University of Lausanne
University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunexpress Pty Ltd.
Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Engages in creating molecular diagnostics for sepsis | Health Technology |
Diagnoplex SA
Diagnoplex SA Medical SpecialtiesHealth Technology Develops molecular diagnostics for colon cancer | Health Technology |
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Health Technology |
















